GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
118 hedge funds and large institutions have $336M invested in G1 Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
52% less capital invested
Capital invested by funds: $699M → $336M (-$362M)
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $1.76M
Holders
118
Holding in Top 10
1
Calls
$2K
Puts
$1.76M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$8.14M | |
| 3 | +$2.7M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.49M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.09M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$15.8M | |
| 3 | -$5.59M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$4.55M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.53M |